Taiwan’s Executive Yuan Science & Technology Advisory Group recently published ‘Spotlight on Taiwan Bio-Industries’, which introduces various aspects of the Taiwan biotechnology industry, including global competitiveness, industry highlights, investment incentives and more.

In the spotlight Roger Samuelsson, SHL Group president and CEO, was quoted: “The hospitable environment and manufacturing expertise available in Taiwan has helped SHL to grow from a small medical device company into the world’s largest privately owned designer, developer and manufacturer of auto injectors we are today. The diverse mix of staff backgrounds we have is one of the key successes that contributed to this achievement and we will continue to work with the rich resources Taiwan has to offer to overcome new challenges and grow together as a company.”

All of SHL’s Taiwan manufacturing based facilities are located in the Taoyuan area and the company continues to benefit from the many strategic advantages this industrial park region has to offer.